Explore the detailed record of transactions filed by Stigall l. Jeremy, Chief Executive Officer. Insider active across 1 company, notably ClearPoint Neuro, Inc.. In total, 1 reports have been recorded. Activity tracked since 10 June 2022. The latest transaction was filed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Jeremy L. Stigall is the General Manager at ClearPoint Neuro, Inc., where he oversees operations related to biologics and drug delivery. His role is crucial for managing projects and optimizing processes within the company. With extensive expertise in the sector, he strives to enhance efficiency and innovation.